Search
for
Sort by
Research 571–600 of 578
- Ginseng in Hair Growth and Viability
- Use of intramuscular triamcinolone acetonide in intermediate responders to janus kinase inhibition for alopecia areata: Case report
- Congenital Trichomegaly of the Eyelashes
- Medical Therapies
- Tratamiento de la alopecia areata, un recorrido desde las opciones terapéuticas clásicas hasta los nuevos fármacos aparecidos en los últimos años
- Proceedings of the Ninth World Congress for Hair Research (2015)
- Determination of 13 janus kinase inhibitors in anti-alopecia cosmetics by ultra-high performance liquid chromatography-tandem triple quadrupole composite linear ion trap mass spectrometry
- SnapshotDx Quiz: April 2022
- Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata
- Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA)
- Ruxolitinib for the treatment of severe alopecia areata
- Ruxolitinib protects skin stem cells and maintains skin homeostasis in murine graft-versus-host disease
- Two cases of alopecia areata treated with ruxolitinib: a discussion of ideal dosing and laboratory monitoring
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- Complete Regrowth of Beard Hair with Ruxolitinib in an Alopecia Universalis Patient
- Unexpected Hair Regrowth in a Patient with Longstanding Alopecia Universalis During Treatment of Recalcitrant Dermatomyositis with the Janus Kinase Inhibitor Ruxolitinib
- Ruxolitinib found to cause eyelash growth: a case report
- Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective
- The use of topical ruxolitinib 1.5% cream in frontal fibrosing alopecia: A case report
- Ruxolitinib 1.5% Topical Cream for the Treatment of Pediatric Alopecia Areata
- Alopecia Universalis and Chronic Graft-vs-Host Disease Treated With Ruxolitinib
- Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients with APS-1
- Delayed granulomatous eruption of the nose associated with ruxolitinib
- Off‐Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives
- Ruxolitinib reverses alopecia areata via a triple mechanism: JAK-STAT inhibition, localized oxidative stress attenuation and selective apoptosis modulation
- Ruxolitinib: A novel molecule in the management of dermatological disorders
- Overcoming genetic drivers in alopecia areata: hair regrowth in a patient with <i>AIRE</i> gene mutation (autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy, APECED syndrome) treated with ruxolitinib
- A Successful Treatment of Alopecia Universalis with Ruxolitinib
- A Single Subcutaneous Dose of BMD-1141 Stimulates Hair Regrowth Comparable to Daily, High-Dose Ruxolitinib in a Mouse Model of Alopecia Areata.
- BH02 Overcoming genetic drivers in alopecia areata: hair regrowth in a patient with the <i>AIRE</i> gene mutation treated with ruxolitinib